Anton Balazh / Shutterstock.com
20 June 2014Big PharmaAndrew Wright and Tom Harding
Not just for medicaments: broadening horizons in Europe
A recent decision by the Board of Appeal (BoA) of the European Patent Office (EPO), T 2003/08, has changed the criteria for second medical use patent protection in Europe. Here we examine the implications for protection by second medical use claims, with a focus on areas that may not fit the traditional concept of a ‘medicament’.
